Treat-to-Target Outcomes With Tapinarof Cream 1% in Phase 3 Trials for Plaque Psoriasis

Armstrong AW, Bissonnette R, Chovatiya R, Bhutani T, Brown PM, Tallman AM, Papp KA. Treat-to-Target Outcomes With Tapinarof Cream 1% in Phase 3 Trials for Plaque Psoriasis. Cutis. 2024 Oct;114(4):122-127. doi: 10.12788/cutis.1112. PMID: 39621574.


Related Posts